The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial (HALT)
The Holding Area LINQ Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial Designed to Occur in the Holding Area of a Hospital Operating Room or Cardiac Catheterization/Electrophysiology Laboratory
Sponsor: Holy Cross Hospital, Florida
A observational or N/A phase clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Holy Cross Hospital, Florida and has accumulated 9 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2022 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Feb 2022 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Feb 2018 — Mar 2018 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Active Not Recruiting NA
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Holy Cross Hospital, Florida
- Medtronic
For direct contact, visit the study record on ClinicalTrials.gov .